Lead Biostatistician
Holmusk Inc., Singapore, Singapore
Joshua, MSc, is currently Lead Biostatistician and Senior Manager (RWE Analytics) at Holmusk Singapore. He comes with a wealth of experience in research design and biostatistical application, and currently oversees a dynamic data analytic team in providing custom analytics services in the behavorial health space, leveraging on both claims databases and Neuroblu, Holmusk's proprietary behavorial health platform consisting of more than 1.5 million patients lives. These projects have provided evidence to enable people to understand the existing treatment landscape in behavorial health and allows providers/manufacturers to improve the way patients with behavorial health disorders are treated.
Prior to joining Holmusk, Joshua led Biostatistics departments in the pharmaceutical industry, healthcare institution, and health tech companies. His expertise lie in behavorial health, infectious diseases, oncology and cardiovascular diseases. Joshua enjoys scientific research and has published widely in peer-reviewed international journals, including Emerging Infectious Diseases, Scientific Reports, British Journal of General Practice, Epidemiology & Infection, and PLOS One. His current research interest lies in understanding more about the treatment landscape, symptomology and clinical outcomes of patients with major depressive disorder, attention-deficit/hyperactivity disorder, and schizophrenia in real-world practice.